Escitalopram and Drop attacks - a phase IV clinical study of FDA data

Summary:

Drop attacks is reported as a side effect among people who take Escitalopram (escitalopram oxalate), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Paracetamol, and have Abnormal behavior.

The phase IV clinical study analyzes which people have Drop attacks when taking Escitalopram. It is created by eHealthMe based on reports of 75,134 people who have side effects when taking Escitalopram from the FDA, and is updated regularly.

What is Escitalopram?

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,080 Escitalopram users. Check the latest studies of Escitalopram.

What is Drop attacks?

Drop attacks (sudden spontaneous falls while standing or walking) is found to be associated with 146 drugs and 236 conditions by eHealthMe. Check the latest studies of Drop attacks.

On Jul, 15, 2026

75,134 people reported to have side effects when taking Escitalopram.
Among them, 11 people (0.01%) have Drop attacks.

Among these 11 people:

How long have people been on Escitalopram when they have Drop attacks? *

What is the gender of people who have Drop attacks when taking Escitalopram? *

female: 80 %
male: 20 %

What is the age of people who have Drop attacks when taking Escitalopram? *

What are other drugs people take besides Escitalopram? *

What are other side effects people have besides Drop attacks? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 63.64%
Fall: 2 people, 18.18%
Drowsiness: 2 people, 18.18%
Fainting (loss of consciousness and postural tone): 1 person, 9.09%

What are the existing conditions these people have? *

Abnormal Behavior: 2 people, 18.18%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 9.09%
Neuralgia (pain in one or more nerves): 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram and have Drop attacks?

- Check whether Drop attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Escitalopram:

Escitalopram (78,080 reports)

Drop attacks treatments and more:

Drop attacks (789 reports)

Browse all side effects of Escitalopram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drop attacks:

Drop attacks (146 drugs)

Browse all the conditions that are associated with Drop attacks:

Drop attacks (236 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Escitalopram) and Escitalopram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.